129 related articles for article (PubMed ID: 32268189)
1. About the impact of superassociation of hydrophobic ion pairs on membrane permeability.
Shahzadi I; Nazir I; Nhu Quynh Phan T; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2020 Jun; 151():1-8. PubMed ID: 32268189
[TBL] [Abstract][Full Text] [Related]
2. Self-emulsifying drug delivery systems: A versatile approach to enhance the oral delivery of BCS class III drug via hydrophobic ion pairing.
Asad M; Rasul A; Abbas G; Shah MA; Nazir I
PLoS One; 2023; 18(6):e0286668. PubMed ID: 37294790
[TBL] [Abstract][Full Text] [Related]
3. Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction?
Phan TNQ; Le-Vinh B; Efiana NA; Bernkop-Schnürch A
J Drug Target; 2019 Nov; 27(9):1017-1024. PubMed ID: 30776924
[No Abstract] [Full Text] [Related]
4. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems.
Griesser J; Hetényi G; Moser M; Demarne F; Jannin V; Bernkop-Schnürch A
Int J Pharm; 2017 Mar; 520(1-2):267-274. PubMed ID: 28188875
[TBL] [Abstract][Full Text] [Related]
5. Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs.
Bonengel S; Jelkmann M; Abdulkarim M; Gumbleton M; Reinstadler V; Oberacher H; Prüfert F; Bernkop-Schnürch A
J Control Release; 2018 Mar; 273():21-29. PubMed ID: 29355620
[TBL] [Abstract][Full Text] [Related]
6. Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugs.
Miller JM; Dahan A; Gupta D; Varghese S; Amidon GL
J Control Release; 2009 Jul; 137(1):31-7. PubMed ID: 19264104
[TBL] [Abstract][Full Text] [Related]
7. Hydrophobic H-bond pairing: A novel approach to improve membrane permeability.
Nazir I; Shahzadi I; Jalil A; Bernkop-Schnürch A
Int J Pharm; 2020 Jan; 573():118863. PubMed ID: 31765777
[TBL] [Abstract][Full Text] [Related]
8. Self-emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release.
Nazir I; Asim MH; Dizdarević A; Bernkop-Schnürch A
Int J Pharm; 2019 Apr; 561():197-205. PubMed ID: 30836151
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery.
Ismail R; Phan TNQ; Laffleur F; Csóka I; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2020 Jul; 152():10-17. PubMed ID: 32371152
[TBL] [Abstract][Full Text] [Related]
10. Toluidine blue O photosensitizer combined with caffeic acid improves antibacterial performance by increasing the permeability of cell membrane.
Gu X; Yuan H; Li C; Xu L; Li S; Yu D
Colloids Surf B Biointerfaces; 2024 Jan; 233():113657. PubMed ID: 38000122
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the impact of multivalent metal ions on the permeation behavior of Dolutegravir sodium.
Grießinger JA; Hauptstein S; Laffleur F; Netsomboon K; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2016; 42(7):1118-26. PubMed ID: 26552713
[TBL] [Abstract][Full Text] [Related]
12. Enhancement and in vitro evaluation of amifostine permeation through artificial membrane (PAMPA) via ion pairing approach and mechanistic selection of its optimal counter ion.
Samiei N; Shafaati A; Zarghi A; Moghimi HR; Foroutan SM
Eur J Pharm Sci; 2014 Jan; 51():218-23. PubMed ID: 24161609
[TBL] [Abstract][Full Text] [Related]
13. A novel in situ hydrophobic ion paring (HIP) formulation strategy for clinical product selection of a nanoparticle drug delivery system.
Song YH; Shin E; Wang H; Nolan J; Low S; Parsons D; Zale S; Ashton S; Ashford M; Ali M; Thrasher D; Boylan N; Troiano G
J Control Release; 2016 May; 229():106-119. PubMed ID: 27001894
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide?
Dumont C; Beloqui A; Miolane C; Bourgeois S; Préat V; Fessi H; Jannin V
Int J Pharm; 2020 Aug; 586():119581. PubMed ID: 32603838
[TBL] [Abstract][Full Text] [Related]
15. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation.
Shahzadi I; Dizdarević A; Efiana NA; Matuszczak B; Bernkop-Schnürch A
J Colloid Interface Sci; 2018 Dec; 531():253-260. PubMed ID: 30036849
[TBL] [Abstract][Full Text] [Related]
16. Binding interactions of Toluidine Blue O with Escherichia coli DNA: formation of bridged structure.
Ilanchelian M; Ramaraj R
J Fluoresc; 2011 Jul; 21(4):1439-53. PubMed ID: 21344224
[TBL] [Abstract][Full Text] [Related]
17. Novel skin penetrating berberine oleate complex capitalizing on hydrophobic ion pairing approach.
Torky AS; Freag MS; Nasra MMA; Abdallah OY
Int J Pharm; 2018 Oct; 549(1-2):76-86. PubMed ID: 30053489
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic Ion Pairing of Small Molecules: How to Minimize Premature Drug Release from SEDDS and Reach the Absorption Membrane in Intact Form.
Spleis H; Federer C; Claus V; Sandmeier M; Bernkop-Schnürch A
ACS Biomater Sci Eng; 2023 Mar; 9(3):1450-1459. PubMed ID: 36786693
[TBL] [Abstract][Full Text] [Related]
19. Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir.
Miller JM; Dahan A; Gupta D; Varghese S; Amidon GL
Mol Pharm; 2010 Aug; 7(4):1223-34. PubMed ID: 20536260
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different intestinal epithelia as models for absorption enhancement studies.
Legen I; Salobir M; Kerc J
Int J Pharm; 2005 Mar; 291(1-2):183-8. PubMed ID: 15707745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
